Article Details

Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical ...

Retrieved on: 2020-12-08 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical .... View article details on hiswai:

Excerpt

All of the company's existing investors, OrbiMed, Novo Holdings, <b>US Venture</b> <b>Partners</b> (USVP), Deerfield Management, New Leaf Ventures and ...

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up